1,121 results on '"Fedorak, Richard N."'
Search Results
2. Early Initiation of Tumor Necrosis Factor Antagonist–Based Therapy for Patients With Crohn’s Disease Reduces Costs Compared With Late Initiation
3. Heterogeneity in Definitions of Efficacy and Safety Endpoints for Clinical Trials of Crohn’s Disease: A Systematic Review
4. Heterogeneity in Definitions of Endpoints for Clinical Trials of Ulcerative Colitis: A Systematic Review for Development of a Core Outcome Set
5. A BACH2 Gene Variant Is Associated with Postoperative Recurrence of Crohn's Disease
6. A randomised phase I study of etrolizumab (rhuMAb β7) in moderate to severe ulcerative colitis
7. The Costs of Industry-Sponsored Medical Device Clinical Trials in Alberta
8. Metabolomic Profiles Are Gender, Disease and Time Specific in the Interleukin-10 Gene-Deficient Mouse Model of Inflammatory Bowel Disease
9. Biosimilars in the Treatment of Inflammatory Bowel Disease
10. An overview of clinical decision support systems: benefits, risks, and strategies for success
11. Incidence Rates for Surgery in Crohn’s Disease Have Decreased: A Population-based Time-trend Analysis
12. IBDoc Canadian User Performance Evaluation
13. The oral toll-like receptor-7 agonist GS-9620 in patients with chronic hepatitis B virus infection
14. Larazotide Acetate for Persistent Symptoms of Celiac Disease Despite a Gluten-Free Diet: A Randomized Controlled Trial
15. The Probiotic VSL#3 Has Anti-inflammatory Effects and Could Reduce Endoscopic Recurrence After Surgery for Crohn's Disease
16. Inflammatory Bowel Disease, Exercise
17. Prebiotics, Probiotics, Antibiotics, and Nutritional Therapies in IBD
18. Crohn's disease outpatients treated with adalimumab have an earlier secondary loss of response and requirement for dose escalation compared to infliximab: A real life cohort study
19. Real-life Treatment Paradigms Show Infliximab Is Cost-effective for Management of Ulcerative Colitis
20. Adalimumab versus infliximab for the treatment of moderate to severe ulcerative colitis in adult patients naïve to anti-TNF therapy: An indirect treatment comparison meta-analysis
21. Phenotypic Features of Crohn's Disease Associated With Failure of Medical Treatment
22. Methotrexate in Combination With Infliximab Is No More Effective Than Infliximab Alone in Patients With Crohn's Disease
23. Probiotics in Ulcerative Colitis
24. A Distinctive Urinary Metabolomic Fingerprint Is Linked With Endoscopic Postoperative Disease Recurrence in Crohn’s Disease Patients
25. Within-Stool and Within-Day Sample Variability of Fecal Calprotectin in Patients With Inflammatory Bowel Disease: A Prospective Observational Study
26. Endospore forming bacteria may be associated with maintenance of surgically-induced remission in Crohn’s disease
27. Clinical validation of a novel urine-based metabolomic test for the detection of colonic polyps on Chinese population
28. Urine-based metabolomic analysis of patients with Clostridium difficile infection: a pilot study
29. Epithelial Cell Extrusion Zones Observed on Confocal Laser Endomicroscopy Correlates with Immunohistochemical Staining of Mucosal Biopsy Samples
30. Breaks in the wall: increased gaps in the intestinal epithelium of irritable bowel syndrome patients identified by confocal laser endomicroscopy (with videos)
31. Urinary NMR metabolomic profiles discriminate inflammatory bowel disease from healthy
32. Primary Outcomes From a Phase 3, Randomized, Double-Blind, Active-Controlled Trial of Surotomycin in Subjects With Clostridium difficile Infection
33. Prebiotic Supplementation Following Ileocecal Resection in a Murine Model is Associated With a Loss of Microbial Diversity and Increased Inflammation
34. Noninvasive Fecal Immunochemical Testing and Fecal Calprotectin Predict Mucosal Healing in Inflammatory Bowel Disease: A Prospective Cohort Study
35. Challenges to the Design, Execution, and Analysis of Randomized Controlled Trials for Inflammatory Bowel Disease
36. Small bowel fibrosis and systemic inflammatory response after ileocolonic anastomosis in IL-10 null mice
37. Risedronate improves bone mineral density in Crohn's disease: A two year randomized controlled clinical trial
38. Increased epithelial gaps in the small intestines of patients with inflammatory bowel disease: density matters
39. Short bowel syndrome
40. Certolizumab Pegol in Patients With Moderate to Severe Crohn's Disease and Secondary Failure to Infliximab
41. Tumor Necrosis Factor-α Monoclonal Antibodies in the Treatment of Inflammatory Bowel Disease: Clinical Practice Pharmacology
42. Peptic ulcer bleeding outcomes adversely affected by end-stage renal disease
43. Clinical Experience with Infliximab for Crohn’s Disease: The First 100 Patients in Edmonton, Alberta
44. The sensitivity and specificity of guaiac and immunochemical fecal occult blood tests for the detection of advanced colonic adenomas and cancer
45. Intravenous Injection of Endogenous Microbial Components Abrogates DSS-Induced Colitis
46. A Randomized Trial of Ustekinumab, a Human Interleukin-12/23 Monoclonal Antibody, in Patients With Moderate-to-Severe Crohn's Disease
47. Treatment of Active Crohn's Disease With MLN0002, a Humanized Antibody to the α4β7 Integrin
48. Allopurinol to Prevent Pancreatitis After Endoscopic Retrograde Cholangiopancreatography: A Randomized Placebo-Controlled Trial
49. Naturally Occurring Glycoalkaloids in Potatoes Aggravate Intestinal Inflammation in Two Mouse Models of Inflammatory Bowel Disease
50. Oral Administration of Curcumin Emulsified in Carboxymethyl Cellulose Has a Potent Anti-inflammatory Effect in the IL-10 Gene-Deficient Mouse Model of IBD
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.